ELISA kit Offers Enhanced Diagnosis of Zika Virus Infection
By LabMedica International staff writers Posted on 27 Aug 2018 |
Image: The new Anti-Zika Virus IgAM ELISA kit detects both IgM and IgA antibodies (Photo courtesy of EUROIMMUN).
An ELISA kit that measures anti-Zika virus antibodies of both the IgM and IgA classes was shown to accurately diagnose the acute phase of the infection even in patients with prior flavivirus exposure.
Specific anti-Zika virus IgM response may be absent in individuals who have had previous contact with a flavivirus through infection or vaccination against dengue, yellow fever, tick-borne encephalitis, Japanese encephalitis, or West Nile viruses. In such cases, determination of specific IgA can facilitate diagnosis of acute Zika virus infection.
To this end, EUROIMMUN AG (Luebeck, Germany) developed the Anti-Zika Virus IgAM ELISA kit. The rationale behind the assay was based on findings that while some patients with an acute Zika virus infection did not exhibit both specific IgM and IgA antibodies, all tested samples were reactive for at least one of the two parameters. Therefore, combined testing for both IgM and IgA would be beneficial for reliable diagnostics of acute Zika virus infections.
Serum samples from 31 patients with confirmed acute Zika virus infections from the Dominican Republic (where Zika and dengue viruses are endemic) and 40 patients from Vietnam with acute dengue virus infection were tested with the Anti-Zika Virus IgAM ELISA kit. Results revealed a sensitivity of 100% (31/31) and a specificity of 95% (38/40). In comparison, the single parameter Anti-Zika Virus IgM kit demonstrated a sensitivity of 29% (9/31) and a specificity of 100% (40/40). Thus, combined detection of both antibody classes rather than only IgM led to a threefold increase in the sensitivity for acute Zika virus infections without a significant loss of specificity.
Specific anti-Zika virus IgM response may be absent in individuals who have had previous contact with a flavivirus through infection or vaccination against dengue, yellow fever, tick-borne encephalitis, Japanese encephalitis, or West Nile viruses. In such cases, determination of specific IgA can facilitate diagnosis of acute Zika virus infection.
To this end, EUROIMMUN AG (Luebeck, Germany) developed the Anti-Zika Virus IgAM ELISA kit. The rationale behind the assay was based on findings that while some patients with an acute Zika virus infection did not exhibit both specific IgM and IgA antibodies, all tested samples were reactive for at least one of the two parameters. Therefore, combined testing for both IgM and IgA would be beneficial for reliable diagnostics of acute Zika virus infections.
Serum samples from 31 patients with confirmed acute Zika virus infections from the Dominican Republic (where Zika and dengue viruses are endemic) and 40 patients from Vietnam with acute dengue virus infection were tested with the Anti-Zika Virus IgAM ELISA kit. Results revealed a sensitivity of 100% (31/31) and a specificity of 95% (38/40). In comparison, the single parameter Anti-Zika Virus IgM kit demonstrated a sensitivity of 29% (9/31) and a specificity of 100% (40/40). Thus, combined detection of both antibody classes rather than only IgM led to a threefold increase in the sensitivity for acute Zika virus infections without a significant loss of specificity.
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability